GGrantIndex
Sort

17,828 grants matching crispr

Enabling Plant Natural Product Biosynthesis by Debugging Heterologous Protein Expression in Yeast

$395,836
Mark Alan Blenner · University Of Delaware · R35 · FY2023 · GM

Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia

$395,738
Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R37 · FY2022 · CA

Role of BAZ2A in MLL-r leukemia and therapeutic response

$395,738
Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA

Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia

$395,738
Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R37 · FY2020 · CA

Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia

$395,738
Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R37 · FY2021 · CA

Role of BAZ2A in MLL-r leukemia and therapeutic response

$395,738
Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA

Role of BAZ2A in MLL-r leukemia and therapeutic response

$395,738
Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA

Combinational targeting the feed forward epigenetic circuitry in mixed lineage leukemia

$395,738
Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R37 · FY2019 · CA

Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems

$395,717
Manish Aghi · University Of California, San Francisco · R01 · FY2022 · CA

CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer

$395,674
Jun Lu · Yale University · R33 · FY2020 · CA

CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer

$395,674
Jun Lu · Yale University · R33 · FY2018 · CA

Targeting epigenetic abnormalities to inhibit cutaneous squamous cell carcinoma

$395,669
Masaoki Kawasumi · University Of Washington · R01 · FY2023 · CA

Systematic Genetic Dissection of Human Erythropoiesis

$395,625
Vijay Ganesh Sankaran · Boston Children'S Hospital · R01 · FY2014 · DK

Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy

$395,588
Yibin Yang · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · CA

Genetic editing and cell therapy for correction of CLCN7 mutations in osteopetrosis

$395,537
Christian E Jacome-Galarza · Brigham And Women'S Hospital · R01 · FY2024 · AR

Enabling Plant Natural Product Biosynthesis by Debugging Heterologous Protein Expression in Yeast

$395,520
Mark Alan Blenner · University Of Delaware · R35 · FY2021 · GM

An in vivo CRISPR-Cas9 genetic screen in murine primary T cells to discover metabolic regulators of follicular B helper T (Tfh) cell differentiation

$395,514
Joseph E Craft · Yale University · R61 · FY2017 · AR

Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype

$395,487
Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2024 · CA

Master regulator transcription factors promote esophageal neoplastic evolution

$395,480
De-Chen Lin · Cedars-Sinai Medical Center · R37 · FY2020 · CA

Manipulation of innate immunity by Polyomavirus T antigens

$395,252
James M Pipas · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI

Cancer Center Support (Core) Grant

$395,141
Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2016 · CA

Nucleolar Genomics During Early Mammalian Development

$395,014
Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · U01 · FY2018 · DA

Nucleolar Genomics During Early Mammalian Development

$395,014
Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · U01 · FY2017 · DA

Nucleolar Genomics During Early Mammalian Development

$395,013
Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · U01 · FY2015 · DA

Nucleolar Genomics During Early Mammalian Development

$395,012
Paul D. Kaufman · Univ Of Massachusetts Med Sch Worcester · U01 · FY2016 · DA